selected publications
-
Signaling-to-chromatin pathways in the immune system.
Immunological reviews.
2021
Review
GET IT
Times cited: 5 -
Histone H3.3 phosphorylation amplifies stimulation-induced transcription.
Nature.
2020
Academic Article
GET IT
Times cited: 61 - Gene regulatory networks STARR-ing B cells. Nature immunology. 2020 Comment GET IT
-
MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2.
Epigenetics & chromatin.
2019
Academic Article
GET IT
Times cited: 30 -
Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer.
Oncogene.
2019
Academic Article
GET IT
Times cited: 37 -
Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity.
Epigenetics.
2017
Academic Article
GET IT
Times cited: 7 -
MeCP2_E1 N-terminal modifications affect its degradation rate and are disrupted by the Ala2Val Rett mutation.
Human molecular genetics.
2017
Academic Article
GET IT
Times cited: 14 -
MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
Advances in experimental medicine and biology.
2017
Review
GET IT
Times cited: 9 -
HMGNs: The enhancer charmers.
BioEssays : news and reviews in molecular, cellular and developmental biology.
2015
Review
GET IT
Times cited: 10 -
Circadian cycle-dependent MeCP2 and brain chromatin changes.
PloS one.
2015
Academic Article
GET IT
Times cited: 19 -
MeCP2: the long trip from a chromatin protein to neurological disorders.
Trends in molecular medicine.
2014
Review
GET IT
Times cited: 74 -
An increase in MECP2 dosage impairs neural tube formation.
Neurobiology of disease.
2014
Academic Article
GET IT
Times cited: 17 -
Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.
Oncogene.
2013
Academic Article
GET IT
Times cited: 104 -
Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain.
Nucleic acids research.
2013
Academic Article
GET IT
Times cited: 18 -
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
The Journal of clinical investigation.
2012
Academic Article
GET IT
Times cited: 362